Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1975 Mar;53(3):419–421. doi: 10.1111/j.1476-5381.1975.tb07378.x

Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice.

G M Anlezark, B S Meldrum
PMCID: PMC1666448  PMID: 1173346

Abstract

Audiogenic seizures in DBA/2 mice have been studied after administration of drugs believed to act as dopamine agonists. Apomorphine at 0.4 mg/kg delays all phases of the response, the tonic phase is absent after 2.0 mg/kg; the clonic phase is abolished by 10 mg/kg. Ergocornine (0.5-8.0 mg/kg) produces effects on the latency and occurrence of seizure stages similar to those of apomorphine. Piribedil, ET 495 (4-100 mg/kg) is less potent; even after 100 mg/kg clonic and tonic phases occurred in 50% of the mice.

Full text

PDF
419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andén N. E., Rubenson A., Fuxe K., Hökfelt T. Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol. 1967 Sep;19(9):627–629. doi: 10.1111/j.2042-7158.1967.tb09604.x. [DOI] [PubMed] [Google Scholar]
  2. Boggan W. O., Seiden L. S. Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice. Physiol Behav. 1971 Mar;6(3):215–217. doi: 10.1016/0031-9384(71)90028-x. [DOI] [PubMed] [Google Scholar]
  3. Corrodi H., Farnebo L. O., Fuxe K., Hamberger B., Ungerstedt U. ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors. Eur J Pharmacol. 1972 Nov;20(2):195–204. doi: 10.1016/0014-2999(72)90149-5. [DOI] [PubMed] [Google Scholar]
  4. Dow R. C., Hill A. G., McQueen J. K. Proceedings: Effects of some dopamine receptor stimulants on cobalt-induced epilepsy in the rat. Br J Pharmacol. 1974 Sep;52(1):135P–135P. [PMC free article] [PubMed] [Google Scholar]
  5. Ernst A. M. Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia. 1967;10(4):316–323. doi: 10.1007/BF00403900. [DOI] [PubMed] [Google Scholar]
  6. Fuxe K., Corrodi H., Hökfelt T., Lidbrink P., Ungerstedt U. Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation. Med Biol. 1974 Apr;52(2):121–132. [PubMed] [Google Scholar]
  7. LEHMANN A. CONTRIBUTION A L''ETUDE PSYCHOPHYSIOLOGIQUE ET NEUROPHARMACOLOGIQUE DE L'EPILEPSIE ACOUSTIQUE DE LA COURIS ET DU RAT. II. ETUDE EXP'ERIMENTALE. Agressologie. 1964 Jul-Aug;5:311–CONTD. [PubMed] [Google Scholar]
  8. Lehmann A. Audiogenic seizures data in mice supporting new theories of biogenic amines mechanisms in the central nervous system. Life Sci. 1967 Jul 1;6(13):1423–1431. doi: 10.1016/0024-3205(67)90190-7. [DOI] [PubMed] [Google Scholar]
  9. McKenzie G. M., Soroko F. E. The effects of apomorphine, (+)-amphetamine and L-dopa on maximal electroshock convulsions--a comparative study in the rat and mouse. J Pharm Pharmacol. 1972 Sep;24(9):696–701. doi: 10.1111/j.2042-7158.1972.tb09092.x. [DOI] [PubMed] [Google Scholar]
  10. Miller R. J., Iversen L. L. Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495). Naunyn Schmiedebergs Arch Pharmacol. 1974;282(2):213–216. doi: 10.1007/BF00499035. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES